Grifols Biologicals, Inc.

ACTIVE

加利福尼亚州洛杉矶县, California, United StatesSubsidiary

Part of 基立福

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

66.7%

Trial Status Distribution

Active, not recruiting

100.0%

Clinical Trials

Trials sponsored by this organization (3)

This is a multicenter, multinational, prospective, single-arm, nonrandomized, open-label study of approximately 25 male subjects with congenital hemophilia A with FVIII inhibitors who will receive their first (primary)treatment with Alphanate. The study will be conducted at approximately 20 study centers.

Phase 1

Active, not recruiting

May 202125 participants

This is a multicenter, multinational, prospective,single-arm, nonrandomized, open-label study of approximately 25 male subjects with congenital hemophilia A with FVIII inhibitors who will receive their first (primary) ITI treatment with Alphanate.The study will be conducted at approximately 20 study centers.

Phase 1

Active, not recruiting

Jun 201625 participants

EFFICACY AND SAFETY OF FACTOR IX (FIX) CONTAINED IN ALPHANINE® AND ITS PHARMACOKINETIC COMPARISON WITH BENEFIX® IN PATIENTS WITH SEVERE HEREDITARY HAEMOPHILIA B (Follow-up study of the trial IG404: EFFICACY AND SAFETY OF FACTOR IX (FIX) CONTAINED IN ALPHANINE IN PATIENTS WITH SEVERE HEREDITARY HAEMOPHILIA B)

Active, not recruiting

Jun 2008

Approvals

Approvals by Agency

PHILIPPINES

Philippines FDA

Approvals

Recent Approvals

News

No news articles found

Back to Organizations